Lems, W., Lodder, M., Lips, P., Bijlsma, J., GEUSENS, Pieter [1196], Schrameijer, N., ...
Alendronate has been described to have a bone-sparing effect in patients treated with moderate and high dosages of prednisone for heterogeneous diseases, however no data are available on groups of...
Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis (2006)
Van Staa, T., GEUSENS, Pieter [1196], Bijlsma, J., Leufkens, H., Cooper, C.
Objective. To determine whether patients with rheumatoid arthritis (RA) have an increased risk of fracture, and to estimate their long-term absolute fracture risk. Methods. We studied patients with...
Lems, W., Lodder, M., Lips, P., Bijlsma, J., GEUSENS, Pieter [1196], Schrameijer, N., ...
Alendronate has been described to have a bone-sparing effect in patients treated with moderate and high dosages of prednisone for heterogeneous diseases, however no data are available on groups of...
Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis (2006)
Van Staa, T., GEUSENS, Pieter [1196], Bijlsma, J., Leufkens, H., Cooper, C.
Objective. To determine whether patients with rheumatoid arthritis (RA) have an increased risk of fracture, and to estimate their long-term absolute fracture risk. Methods. We studied patients with...
Lems, W., Lodder, M., Lips, P., Bijlsma, J., GEUSENS, Piet, Schrameijer, N., ...
Alendronate has been described to have a bone-sparing effect in patients treated with moderate and high dosages of prednisone for heterogeneous diseases, however no data are available on groups of...
Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis (2006)
Van Staa, T., GEUSENS, Piet, Bijlsma, J., Leufkens, H., Cooper, C.
Objective. To determine whether patients with rheumatoid arthritis (RA) have an increased risk of fracture, and to estimate their long-term absolute fracture risk. Methods. We studied patients with...
Zhang, W., Doherty, M., Arden, N., Bannwarth, B., Bijlsma, J., Gunther, K.-P., ...
Objective: To develop evidence based recommendations for the management of hip osteoarthritis (OA). Methods: The multidisciplinary guideline development group comprised 18 rheumatologists, 4...
Gezonde uiers door geleidbaarheidsmetingen (1991)
Bijlsma, J., Geneijgen, J., Van
Het systeem werkt met on-line geleidbaarheidsmetingen van kwartiermelk en is nu zover ontwikkeld dat het de mogelijkheid biedt het management van de uiergezondheid hier geheel op te baseren.
Van Roon, J. A G, Verhoef, C., Van Roy, J. L A M, Gmelig-Meyling, F., Huber-Bruning, O., Lafeber, F., ...
Objectives—To compare peripheral type 1 (T1) and type 2 (T2) T cell activities in rheumatoid arthritis (RA) patients with that found for osteoarthritic (OA) patients and healthy controls and to...
Lems, W., Jacobs, J., Bijlsma, J., Van Veen, G. J M, Houben, H., Haanen, H., ...
OBJECTIVE—To investigate whether administration of sodium fluoride (NaF) in addition to cyclical etidronate has a positive effect on bone mineral density (BMD) in patients with established...
Mutual antagonism of rheumatoid arthritis and hay fever; a role for type 1/type 2 T cell balance
Verhoef, C., Van Roon, J. A G, Vianen, M., Bruijnzeel-Koomen, C., Lafeber, F., Bijlsma, J.
OBJECTIVES—The balance between interferon γ(IFNγ) and interleukin 4 (IL4) producing T cells (T1 and T2 cells) seems to be of importance in many (auto)immune disorders. In general, T1 cell...
Deforming arthropathy or lupus and rhupus hands in systemic lupus erythematosus
Van Vugt, R M, Derksen, R, Kater, L, Bijlsma, J
OBJECTIVE—Although deforming arthropathy in systemic lupus erythematosus (SLE) is characterised by a number of manifestations, definitive criteria for the different forms have not yet been...
Verhoef, C., Van Roon, J. A G, Vianen, M., Lafeber, F., Bijlsma, J.
OBJECTIVES—The influence of dexamethasone on interleukin 10 (IL10) production and the type 1 (T1)/type 2 (T2) T cell balance found in rheumatoid arthritis (RA) was...
Chronic wrist pain: diagnosis and management. Development and use of a new algorithm
Van Vugt, R. M, Bijlsma, J., Van Vugt, A. C
OBJECTIVE—Chronic wrist pain can be difficult to manage and the differential diagnosis is extensive. To provide guidelines for assessment of the painful wrist an algorithm was developed to...
Pendleton, A, Arden, N, Dougados, M, Doherty, M, Bannwarth, B, Bijlsma, J, ...
BACKGROUND—Osteoarthritis (OA) is the most common joint disease encountered throughout Europe. A task force for the EULAR Standing Committee for Clinical Trials met in 1998 to determine the...
Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial
Van Jaarsveld, C H M, Jacobs, J, Van Der Veen, M J, Blaauw, A, Kruize, A, Hofman, D, ...
OBJECTIVES—To compare three therapeutic strategies using slow acting antirheumatic drugs (SAARDs) in early rheumatoid arthritis (RA), for their disease modifying properties, toxicity, and lag time...
Jacobs, J, Geenen, R, Evers, A, Van Jaarsveld, C H M, Kraaimaat, F, Bijlsma, J
OBJECTIVE—To investigate the short term effects of corticosteroid pulse treatment (CPT) on disease activity, functional ability, and psychological wellbeing of patients with active rheumatoid...
Effectiveness of exercise in patients with osteoarthritis of hip or knee: nine months' follow up
Van Baar, M E, Dekker, J, Oostendorp, R, Bijl, D, Voorn, T., Bijlsma, J
OBJECTIVE—To determine whether the effects of an exercise programme in patients with osteoarthritis of hip or knee are sustained at six and nine months' follow up. METHODS—A randomised, single...
Th2 mediated regulation in RA and the spondyloarthropathies
Van Roon, J A G, Bijlsma, J
Buttgereit, F, Da Silva, J A P, Boers, M, Burmester, G, Cutolo, M, Jacobs, J, ...
In rheumatology and other medical specialties there is a discrepancy between the widespread use and the imprecise designation of glucocorticoid treatment regimens. Verbal descriptions of...
Jordan, K, Arden, N, Doherty, M, Bannwarth, B, Bijlsma, J, Dieppe, P, ...
Objectives: To update the EULAR recommendations for management of knee osteoarthritis (OA) by an evidence based medicine and expert opinion approach.
Van Roon, J A G, Glaudemans, K, Bijlsma, J, Lafeber, F
Background: A large number of activated T cells are found in the joints of patients with rheumatoid arthritis (RA). Interleukin 7 (IL7), a T cell growth factor and a regulator of Th1 and Th2 cytokine...
Furst, D, Breedveld, F, Kalden, J, Smolen, J, Antoni, C, Bijlsma, J, ...
Geusens, P, De Nijs, R N J, Lems, W, Laan, R, Struijs, A, Van Staa, T P, ...
Van De Putte, L B A, Atkins, C, Malaise, M, Sany, J, Russell, A, Van Riel, P L C M, ...
Objective: To evaluate the efficacy and safety of monotherapy with adalimumab in patients with RA for whom previous DMARD treatment has failed.
Determinants of direct costs in Dutch rheumatoid arthritis patients
Verstappen, S, Verkleij, H, Bijlsma, J, Buskens, E, Kruize, A, Heurkens, A, ...
Objectives: To estimate annual direct costs in four distinct disease duration groups (0 to ⩽2, 2 to ⩽6, 6 to ⩽10, and >10 years) of patients with rheumatoid arthritis (RA), to determine...
Kruize, A, Van Bijsterveld, O P, Hene, R, De Wilde, P C M, Feltkamp, T, Kater, L, ...
AIMS—To assess the course of tear gland function of patients with keratoconjunctivitis sicca (KCS) associated with primary (KCS-PSS) or secondary Sjögren's syndrome (KCS-SSS), and of patients with...
Furst, D, Breedveld, F, Kalden, J, Smolen, J, Burmester, G, Bijlsma, J, ...
Verstappen, S, Van Albada-Kuiper..., G A, Bijlsma, J, Blaauw, A, Schenk, Y, Haanen, H, ...
Objective: To describe the frequency and duration of remission in the Utrecht rheumatoid arthritis cohort of patients followed since diagnosis, and the clinical and treatment characteristics of...
Which dose regimen for glucocorticoid pulse therapy in patients with severe refractory RA?
Buttgereit, F, Burmester, G, Bijlsma, J, Durez, P, Nzeusseu, T, Lauwerys, B, ...
Zhang, W, Doherty, M, Arden, N, Bannwarth, B, Bijlsma, J, Gunther, K, ...
Objective: To develop evidence based recommendations for the management of hip osteoarthritis (OA).
Van Roon, J A G, Bijlsma, J, Van De Winkel, J G J, Lafeber, F
Background: Monocytes/macrophages have an important and versatile role in joint inflammation and destruction in rheumatoid arthritis (RA).